This Article Full Text Full Text (PDF) All Versions of this Article: 36/6/1308    most recent 01.STR.0000165901.38039.5fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Birns, J. Articles by Kalra, L. Search for Related Content PubMed PubMed Citation Articles by Birns, J. Articles by Kalra, L. Related Collections Brain Circulation and Metabolism Other arteriosclerosis Cerebral Lacunes

(Stroke. 2005;36:1308.)
© 2005 American Heart Association, Inc.

Comments, Opinions, and Reviews

Blood Pressure Reduction for Vascular Risk

Is There a Price To Be Paid?

From the Department of Stroke Medicine (J.B., L.K.), Guy’s King’s and St Thomas’ School of Medicine, King’s College London, Bessemer Road, London, United Kingdom; and Clinical Neuroscience (H.M.), St George’s Hospital Medical School, Cranmer Terrace, London, United Kingdom.

Correspondence to Dr J. Birns, Department of Stroke Medicine, Guy’s King’s and St Thomas’ School of Medicine, King’s College London, Bessemer Road, London SE5 9PJ United Kingdom. E-mail jonathan.birns{at}kcl.ac.uk

The importance of lowering blood pressure (BP) in hypertensive subjects is well-known and recent studies suggest that lowering of BP in patients who may already be in the normotensive range further reduces the risk of vascular events, particularly stroke. Epidemiological data have also shown that lower BP and antihypertensive treatment may be associated with cognitive impairment once cerebrovascular disease is established. However, the relationship between hypertension and cerebrovascular disease is more complex than suggested by epidemiological or intervention studies. Cerebral imaging studies have shown that cerebral blood flow (CBF) is reduced in areas of small-vessel disease (SVD) and the degree of hypoperfusion correlates with disease severity. Furthermore, impaired neuropsychological performance has been found to correlate with cerebral hypoperfusion in patients with established SVD. These findings raise questions surrounding the desirability of lowering of BP beyond a certain level in such patients. It is conceivable that indiscriminate BP reduction may compromise cerebral perfusion and function in these patients, increasing the risk of cognitive decline and cerebrovascular disease progression. Randomized clinical trials addressing the relationship between antihypertensive treatment and vascular cognitive impairment are lacking. Further studies are therefore needed to assess the cognitive consequences of BP reduction in people with established cerebrovascular disease. This will help to direct appropriate protective strategies and treatments in a vulnerable group of people, many of whom have hypertension and cerebrovascular disease at the same time.

Key Words: cerebrovascular disorders • cognition • hypertension

This article has been cited by other articles:

				R. Zhang, S. Witkowski, Q. Fu, J. A.H.R. Claassen, and B. D. Levine Cerebral Hemodynamics After Short- and Long-Term Reduction in Blood Pressure in Mild and Moderate Hypertension Hypertension, May 1, 2007; 49(5): 1149 - 1155. [Abstract] [Full Text] [PDF]

				T. del Ser, R. Barba, M. M. Morin, J. Domingo, C. Cemillan, M. Pondal, and J. Vivancos Evolution of Cognitive Impairment After Stroke and Risk Factors for Delayed Progression Stroke, December 1, 2005; 36(12): 2670 - 2675. [Abstract] [Full Text] [PDF]